Xact Kapitalforvaltning’s Immunomedics Inc IMMU Stock Holding History

Xact Kapitalforvaltning’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$459K	Hold	34,018	–	–	0.01%	803
2019 Q4	$720K	Buy	34,018 +10,100	+42%	+$178K	0.01%	776
2019 Q3	$317K	Hold	23,918	–	–	0.01%	1170
2019 Q2	$332K	Hold	23,918	–	–	0.01%	1163
2019 Q1	$459K	Hold	23,918	–	–	0.01%	970
2018 Q4	$341K	Buy	23,918 +4,300	+22%	+$85.4K	0.01%	1155
2018 Q3	$409K	Buy	19,618 +1,700	+9%	+$40.3K	0.01%	1118
2018 Q2	$424K	Sell	17,918 -500	-3%	-$10K	0.01%	1071
2018 Q1	$269K	Buy	18,418 +6,500	+55%	+$106K	0.01%	1317
2017 Q4	$193K	Buy	+11,918	New	+$141K	﹤0.01%	1271

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Xact Kapitalforvaltning's IMMU Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Immunomedics Inc (IMMU) position steady in Q1 2020 at 34,018 shares worth $459K. The position accounts for 0.01% of the portfolio, ranked #803.

Xact Kapitalforvaltning first reported a position in IMMU in Q4 2017 and has held it in 10 quarters since. The position peaked at $720K in Q4 2019. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

Xact Kapitalforvaltning held 34,018 shares of Immunomedics Inc worth $459K as of Q1 2020.
Xact Kapitalforvaltning left its Immunomedics Inc share count unchanged in Q1 2020.
Immunomedics Inc made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #803 holding.
Xact Kapitalforvaltning first reported a position in Immunomedics Inc in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Immunomedics Inc position peaked at $720K in Q4 2019.
220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.